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Introduction
A large ultrasound-based study from Europe revealed
that the overall rate of gallstone disease was 18.8% in
women and 9.5% in men.1 More than 20 million peo-
ple have gallbladder disease in the United States.2 The
introduction of endoscopic retrograde cholangiopan-
creatography and endoscopic sphincterotomy (ES) in
the 1970s has virtually supplanted surgery for the treat-
ment of common bile duct stones (CBDS).2,3 However,
the recurrence rate of CBDS is around 3–21% after
ES and as high as 80% after the first recurrence.4–10
Gallbladder left in situ and large bile duct size (≥15mm)
are associated with the relapse of biliary symptoms in
patients after ES, while bile duct size and a large juxta-
papillary diverticulum (JPD) are associated with recur-
rent bile duct stones (RBDS).11,12 However, elective
cholecystectomy after ES does not significantly reduce
the incidence of recurrent biliary complications and is
not always necessary.13,14 Large bile duct and JPD may
result in bile stasis or impairment of hepatic clear-
ance.15,16 Delayed biliary emptying or hepatic clear-
ance occurred commonly in patients with a history of
choledocholithiasis, even after complete ES.12,17
Quantitative cholescintigraphy (QC) is an ideal non-
invasive test for evaluating hepatic clearance and pre-
dicting the occurrence of RBDS,18–21 but there is still
no effective method for preventing this complication.
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Some drugs such as ursodeoxycholic acid and aspirin
have been employed to prevent gallstone formation in
patients on a very low-calorie diet, but their effects on
RBDS are unknown.22–24 Fatty meal has been shown to
reduce the risk of cholecystectomy and also to improve
hepatic clearance in patients with intact gallbladder
and post-cholecystectomy after ES.25,26 It is question-
able as to whether or not other kinds of food have a
similar impact on hepatic clearance. In the present study,
we compared the effects of fatty and low-fat meals on
QC in patients with abnormal hepatic clearance after ES
and tested the possible factors affecting the recurrence
of CBDS.
Methods
Between April 1999 and October 2003, 139 patients
with choledocholithiasis after ES and complete biliary
clearance received QC to evaluate their hepatic clear-
ance after normalization of liver function. Forty-seven
patients with abnormal QC (45-minute clearance 
of radioisotope < 57%) were enrolled in our study.
Complete ablation of sphincter function in these 47
patients was confirmed by sphincter of Oddi manom-
etry. Sphincter of Oddi manometry was performed as
previously described,16 and the complete ablation of
sphincter function was defined as wide opening of the
papilla and the basal pressure of the sphincter being
< 10 mmHg.
Fasting (routine) QC was performed following
intravenous administration of 8 mCi (296 MBq) of
technetium-99m disofenin (Hepatolite; CIS-US,
Bedford, MA, USA) to patients after overnight fasting.
Imaging was carried out using a large-field gamma
camera with low energy, all-purpose collimator (Siemens
Orbiter 75, Chicago, IL, USA) connected to a com-
puter (Microdelta, Chicago, IL, USA). Data were
recorded with patients in supine position under the
gamma camera. A continuous series of 60 frames of
1-minute duration each was stored on the computer
disk for later analysis. Static views at 1, 2, 4 and 6 hours
were also recorded. A rectangular region of interest
was identified and outlined over the right hepatic lobe,
and a time-activity curve was created. The time to reach
maximal count (Tmax), half time for hepatic clearance
from Tmax (T1/2) and hepatic clearance percentage of
the maximal counts at 45 minutes and 60 minutes
(E45, E60) were calculated for comparison. The ref-
erence values of positive limit were Tmax = 13 minutes;
T1/2 = 30 minutes; E45 = 57%; and E60 = 72%.20
The mean time lag between low-fat meal QC 
performed after fasting QC was 1.4 ± 0.9 months and
between fatty and low-fat meal QC was 1.5 ± 1.4
months. The low-fat meal consisted of 2 pieces of toast,
250 mL of low-fat milk and 250 mL of fruit juice (fat,
0.3g; protein, 13g; carbohydrate, 77g; total, 363kcal),
while the fatty meal consisted of 2 fried eggs, 250 mL
of full-fat milk and 250 mL of fruit juice (fat, 28 g;
protein, 22g; carbohydrate, 12g; total, 388kcal). Meals
were taken 30 minutes before isotope injection and the
rest of the procedure was the same as for fasting QC.
The Department of Medical Research and Education
of Kaohsiung Veterans General Hospital approved
this study, and informed consent was obtained from
each patient.
This was a repeated measures study with a balanced
design in which each of the 47 subjects was observed
at 3 different levels of treatments, namely: fasting
(treatment 1); low-fat meal (treatment 2); and fatty
meal (treatment 3). General linear model of ANOVA
was used to test the differences in hepatic clearance
among the 3 levels of the factor (diet), and Tukey’s
honestly significant difference (HSD) was used as a
multiple comparison test. Furthermore, the possible
factors (age, sex, CBD diameter, intact gallbladder,
presence of juxtapapillary diverticulum, improvement
in hepatic clearance ≥ 5% at 45 minutes or 60 minutes
after meals) affecting the recurrence of CBDS were
analyzed by logistic regression. A p value of < 0.05 was
considered to be significant.
Results
Patients’ characteristics are shown in Table 1. The mean
age of all the patients was 67 ± 11 years; 32 patients
(68%) were male. Twenty-two patients (47%) had
JPD, and 21 patients (44.7%) had an intact gallblad-
der. Twenty-seven (57%) patients had bile duct size
≥ 15 mm. There was no significant difference in fast-
ing E45 with regard to the differences in sex, age,
gallbladder status, presence of JPD and bile duct size
(Table 2). The mean follow-up period was 62 ± 34
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Age > 65 yr vs. ≤ 65 yr 28/19 60/40
Juxtapapillary diverticulum (yes/no) 22/25 47/53
Intact gallbladder (yes/no) 21/26 45/55
Bile duct size ≥ 15 mm vs. < 15 mm 27/20 57/43
Recurrent bile duct stones (yes/no) 12/35 26/74
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months, and the mean recurrence period of CBDS
was 23 ± 13 months.
The QC results are shown in Table 3. The effect
of the diets on hepatic clearance was highly significant
(p < 0.001), as shown by ANOVA. Tukey’s HSD test
further indicated that there were significant improve-
ments in hepatic clearance with the fatty meal (treat-
ment 3) compared to fasting (treatment 1), as well as
with the low-fat meal (treatment 2) compared to fast-
ing (treatment 1), but not between the low-fat and
fatty meals (treatments 2 and 3).
The individual responses to fatty or low-fat meal
revealed by improvement in radioisotope elimination
≥ 5% at 45 or 60 minutes when compared with fasting
QC is shown in Table 4. Although most of the patients
showed a positive response to both types of meals,
some demonstrated a contradictory result. Twelve pa-
tients (26%) developed RBDS during the follow-up
period. Factors including age, sex, bile duct size, intact
gallbladder, presence of JPD, and the influence of meals
on QC did not significantly affect the recurrence of
CBDS (Table 5). All patients tolerated the meals well.
Discussion
QC is a noninvasive test to evaluate hepatic clearance
and biliary emptying.22,27 We chose the region of inter-
est over the right lobe of the liver to avoid higher back-
ground activity over the left liver and bile duct.28,29
The slopes for disappearance of isotope from the region
of the right liver, hilum, and CBD were virtually iden-
tical; hepatic clearance in the right liver is therefore





Male 32 29 ± 11
Female 15 27 ± 11
Age (yr) 0.48
> 65 28 27 ± 12
≤ 65 19 30 ± 11
Juxtapapillary diverticulum 0.41
Yes 22 30 ± 12
No 25 27 ± 11
Intact gallbladder 0.17
Yes 21 26 ± 11
No 26 30 ± 11
Bile duct size (mm) 0.69
≥ 15 27 29 ± 12
< 15 20 27 ± 11
*Data presented as mean ± standard deviation.
Table 4. Individual response to fatty meal or low-fat meal shown
by quantitative cholescintigraphy
Response to Meal Patients (n)
Fatty meal (+)* Low-fat meal (+) 36
Fatty meal (+) Low-fat meal (−)† 5
Fatty meal (−) Low-fat meal (+) 2
Fatty meal (−) Low-fat meal (−) 4
*Increase in radioisotope elimination ≥ 5% at 45 or 60 minutes compared
with fasting quantitative cholescintigraphy; †increase in radioisotope elimi-
nation < 5% or decrease in radioisotope elimination at 45 or 60 minutes
compared with fasting quantitative cholescintigraphy.
Table 3. Results of quantitative cholescintigraphy in 47 patients
after endoscopic sphincterotomy
Fasting Low-fat meal Fatty meal
Tmax (min) 20 ± 7a,b 15 ± 5a,c 14 ± 5b,c
T1/2 (min) 53 ± 22d,e 40 ± 10d,f 37 ± 10e,f
E45 (%) 28 ± 11g,h 41 ± 12g,i 45 ± 12h,i
E60 (%) 43 ± 13j,k 54 ± 10j,l 58 ± 10k,l
a,b,d,e,g,h,j,kp < 0.001; c,f,i,lp > 0.05. Tmax = time to reach maximal radioactivity;
T1/2 = time for decrease from peak to 1/2 maximal radioactivity; E45 and
E60 = percent of maximal radioactivity excreted at 45 and 60 minutes.
Table 5. Possible factors affecting recurrent bile duct stones as analyzed by logistic regression
Factors Recurrence vs. no recurrence OR 95% CI p
Sex (male vs. female) 8/32 vs. 4/15 0.92 0.23–3.70 0.90
Age > 65 yr vs. ≤ 65 yr 5/28 vs. 7/19 0.37 0.10–1.43 0.15
CBD diameter ≥ 1.5 cm vs. < 0.5 cm 8/27 vs. 4/20 1.68 0.43–6.64 0.46
Intact gallbladder (yes vs. no) 6/21 vs. 6/26 1.33 0.36–4.97 0.67
Juxtapapillary diverticulum (yes vs. no) 4/22 vs. 8/25 0.47 0.12–1.86 0.28
Response to fatty meal (yes vs. no) 10/2 vs. 31/4 0.65 0.10–4.07 0.64
Response to low-fat meal (yes vs. no) 11/1 vs. 27/8 3.26 0.36–29.2 0.29
OR = odds ratio; CI = confidence interval; CBD = common bile duct.
comparable to biliary emptying of the CBD in the
absence of biliary obstruction and parenchymal liver
disease.20,27 It has been shown that in asymptomatic
control patients, more than half of the radioisotope
was excreted at 45 minutes after administration.20
However, QC is not sensitive enough to detect the
difference between organic and functional disorders
of the biliary tract, especially in patients with a dilated
bile duct.21 In this study group, the possible organic
obstruction of the bile duct could be excluded by nor-
malization of liver function before QC and low sphinc-
teric basal pressure by sphincter of Oddi manometry.
However, even in the patient who receives complete
ES, bile secreted from the liver may be diverted to the
gallbladder or through the bile duct into the duode-
num, depending on the resistance to the bile flow.
This depends on the contraction state of the gallblad-
der as well as the pressure gradient of the sphincter of
Oddi during duodenal contraction. Following inges-
tion of a meal, the gallbladder contracts actively and
empties the bile. The process is primarily mediated by
the release of cholecystokinin (CCK) since it can be
completely blocked by the administration of a CCK
antagonist.30 The effect on bile flow by the gallblad-
der in contrast to patients without a gallbladder could
be minimized by the administration of artificial CCK
or synthetic fatty meal.31 We used natural fatty food
instead of artificial products or drugs for the study of
hepatic clearance with the same effect on gallbladder,
and it was more physiological and cheaper.26
Intact sphincter of Oddi is a passive resistor to
control the passage of bile flow into the duodenum.
Therefore, bile should pass freely into the duodenum
after ES. In this group of patients under investigation,
all had persistent impairment of hepatic clearance (E45)
even after ES, which was a risk factor for RBDS.19
Theoretically, normalization of hepatic clearance may
minimize the episodes of recurrent bile duct symp-
toms, but no safe and effective medicine or method is
helpful up to now. Although frequent nut consump-
tion may reduce the risk of cholecystectomy for gall-
stone disease in women, further adjustment of fat
consumption did not materially alter the relation.26
We therefore tested the response of patients by using
different types of diets compared to fasting in terms
of hepatic clearance. We found that there were signif-
icant improvements in all the parameters of hepatic
clearance if patients were pretreated by fatty and low-
fat meals compared to fasting. But there was no sig-
nificant difference between the patients pretreated by
fatty versus low-fat meals. However, the response of
hepatic clearance to meals was individualized. Although
there was no direct correlation between responsiveness
to fatty or low-fat meals and RBDS in this study, the
improvement in hepatic clearance was probably via
increase of bile flow after meals, which helps to flush
the bile duct and clear the particles or sandy stones.
The drawbacks of this study were small sample
size and the lack of a standard diet being suggested
after ES. Although we could not figure out the clini-
cal importance of different meals in the prevention of
biliary complications, our study suggests that fat restric-
tion or prolonged fasting may be inappropriate for
patients with CBDS who have received ES. Further
studies are needed to explore the influence of fre-
quency and types of food intake on hepatic clearance
and RBDS.
In conclusion, both fatty and low-fat meals improved
hepatic clearance in most of the patients after ES and
the response was individualized. Therefore, it is possi-
ble to benefit patients in terms of reducing the risk of
RBDS if the eating habit is changed to frequent small
amounts of food instead of prolonged fasting and fat
restriction.
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